Literature DB >> 24712469

Regulatory T cells in autoimmune neuroinflammation.

Markus Kleinewietfeld1, David A Hafler.   

Abstract

Regulatory T cells are the central element for the maintenance of peripheral tolerance. Several subtypes of regulatory T (Treg) cells have been described, and most of them belong to the CD4(+) T-helper (Th) cell lineage. These specific subtypes can be discriminated according to phenotype and function. Forkhead box protein 3 (FoxP3)-expressing natural Treg cells (Tregs) and IL-10-producing, T-regulatory type 1 cells (Tr1) are the best-studied types of CD4(+) regulatory T cells in humans and experimental animal models. It was shown that they play a crucial role during autoimmune neuroinflammation. Both cells types seem to be particularly important for multiple sclerosis (MS). Here, we discuss the role of CD4(+) regulatory T cells in autoimmune neuroinflammation with an emphasis on Tregs and Tr1 cells in MS.
© 2014 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  FoxP3; Tr1; Treg; autoimmunity; multiple sclerosis; regulatory T cells

Mesh:

Substances:

Year:  2014        PMID: 24712469      PMCID: PMC3990868          DOI: 10.1111/imr.12169

Source DB:  PubMed          Journal:  Immunol Rev        ISSN: 0105-2896            Impact factor:   12.988


  165 in total

1.  Effects of natalizumab on circulating B cells, T regulatory cells and natural killer cells.

Authors:  Norman Putzki; Manoj Kumar Baranwal; Barbara Tettenborn; Volker Limmroth; Ernst Kreuzfelder
Journal:  Eur Neurol       Date:  2010-05-05       Impact factor: 1.710

Review 2.  Regulatory T cells in the central nervous system.

Authors:  Daniel E Lowther; David A Hafler
Journal:  Immunol Rev       Date:  2012-07       Impact factor: 12.988

3.  CD4+CD25high regulatory cells in human peripheral blood.

Authors:  C Baecher-Allan; J A Brown; G J Freeman; D A Hafler
Journal:  J Immunol       Date:  2001-08-01       Impact factor: 5.422

4.  Increased frequencies of myelin oligodendrocyte glycoprotein/MHC class II-binding CD4 cells in patients with multiple sclerosis.

Authors:  Khadir Raddassi; Sally C Kent; Junbao Yang; Kasia Bourcier; Elizabeth M Bradshaw; Vicki Seyfert-Margolis; Gerald T Nepom; William W Kwok; David A Hafler
Journal:  J Immunol       Date:  2011-06-08       Impact factor: 5.422

Review 5.  Human regulatory T cells and their role in autoimmune disease.

Authors:  Clare Baecher-Allan; David A Hafler
Journal:  Immunol Rev       Date:  2006-08       Impact factor: 12.988

6.  Naive regulatory T cells: a novel subpopulation defined by resistance toward CD95L-mediated cell death.

Authors:  Benedikt Fritzsching; Nina Oberle; Eva Pauly; Robert Geffers; Jan Buer; Johannes Poschl; Peter Krammer; Otwin Linderkamp; Elisabeth Suri-Payer
Journal:  Blood       Date:  2006-07-25       Impact factor: 22.113

Review 7.  The plasticity of human Treg and Th17 cells and its role in autoimmunity.

Authors:  Markus Kleinewietfeld; David A Hafler
Journal:  Semin Immunol       Date:  2013-11-05       Impact factor: 11.130

8.  Potential regulatory function of human dendritic cells expressing indoleamine 2,3-dioxygenase.

Authors:  David H Munn; Madhav D Sharma; Jeffrey R Lee; Kanchan G Jhaver; Theodore S Johnson; Derin B Keskin; Brendan Marshall; Phillip Chandler; Scott J Antonia; Russell Burgess; Craig L Slingluff; Andrew L Mellor
Journal:  Science       Date:  2002-09-13       Impact factor: 47.728

Review 9.  Epigenetic control of FOXP3 expression: the key to a stable regulatory T-cell lineage?

Authors:  Jochen Huehn; Julia K Polansky; Alf Hamann
Journal:  Nat Rev Immunol       Date:  2009-02       Impact factor: 53.106

10.  Activation-induced FOXP3 in human T effector cells does not suppress proliferation or cytokine production.

Authors:  Sarah E Allan; Sarah Q Crome; Natasha K Crellin; Laura Passerini; Theodore S Steiner; Rosa Bacchetta; Maria G Roncarolo; Megan K Levings
Journal:  Int Immunol       Date:  2007-02-27       Impact factor: 4.823

View more
  88 in total

Review 1.  Neuroimmunotherapies Targeting T Cells: From Pathophysiology to Therapeutic Applications.

Authors:  Stefan Bittner; Heinz Wiendl
Journal:  Neurotherapeutics       Date:  2016-01       Impact factor: 7.620

Review 2.  Control of autoimmune CNS inflammation by astrocytes.

Authors:  Veit Rothhammer; Francisco J Quintana
Journal:  Semin Immunopathol       Date:  2015-07-30       Impact factor: 9.623

3.  Exogenous activation of tumor necrosis factor receptor 2 promotes recovery from sensory and motor disease in a model of multiple sclerosis.

Authors:  Roman Fischer; Tanja Padutsch; Valerie Bracchi-Ricard; Kayla L Murphy; George F Martinez; Niky Delguercio; Nicholas Elmer; Maksim Sendetski; Ricarda Diem; Ulrich L M Eisel; Richard J Smeyne; Roland E Kontermann; Klaus Pfizenmaier; John R Bethea
Journal:  Brain Behav Immun       Date:  2019-06-17       Impact factor: 7.217

4.  Genomewide analyses of pathogenic and regulatory T cells of NOD mice reveal a significant difference in DNA methylation on chromosome X.

Authors:  Dang Sun; Qingsheng Yu; Ping Li; Jianying Shen
Journal:  J Genet       Date:  2016-12       Impact factor: 1.166

5.  Administration of CD4+CD25highCD127-FoxP3+ Regulatory T Cells for Relapsing-Remitting Multiple Sclerosis: A Phase 1 Study.

Authors:  Kamil Chwojnicki; Dorota Iwaszkiewicz-Grześ; Anna Jankowska; Maciej Zieliński; Paweł Łowiec; Mateusz Gliwiński; Małgorzata Grzywińska; Kamil Kowalczyk; Aleksandra Konarzewska; Paulina Glasner; Justyna Sakowska; Julia Kulczycka; Anna Jaźwińska-Curyłło; Marlena Kubach; Bartosz Karaszewski; Walenty Nyka; Edyta Szurowska; Piotr Trzonkowski
Journal:  BioDrugs       Date:  2021-01-05       Impact factor: 5.807

6.  'Neuroinflammation' differs categorically from inflammation: transcriptomes of Alzheimer's disease, Parkinson's disease, schizophrenia and inflammatory diseases compared.

Authors:  Michaela D Filiou; Ahmed Shamsul Arefin; Pablo Moscato; Manuel B Graeber
Journal:  Neurogenetics       Date:  2014-06-15       Impact factor: 2.660

Review 7.  Adjuvants and lymphoma risk as part of the ASIA spectrum.

Authors:  Dana Butnaru; Yehuda Shoenfeld
Journal:  Immunol Res       Date:  2015-02       Impact factor: 2.829

8.  Sodium Benzoate, a Food Additive and a Metabolite of Cinnamon, Enriches Regulatory T Cells via STAT6-Mediated Upregulation of TGF-β.

Authors:  Madhuchhanda Kundu; Susanta Mondal; Avik Roy; Jeffrey L Martinson; Kalipada Pahan
Journal:  J Immunol       Date:  2016-09-07       Impact factor: 5.422

9.  ICAM1+ neutrophils promote chronic inflammation via ASPRV1 in B cell-dependent autoimmune encephalomyelitis.

Authors:  Ryder F Whittaker Hawkins; Alexandre Patenaude; Aline Dumas; Rajiv Jain; Yodit Tesfagiorgis; Steven Kerfoot; Takeshi Matsui; Matthias Gunzer; Patrice E Poubelle; Catherine Larochelle; Martin Pelletier; Luc Vallières
Journal:  JCI Insight       Date:  2017-12-07

10.  Effects of spinal non-viral interleukin-10 gene therapy formulated with d-mannose in neuropathic interleukin-10 deficient mice: Behavioral characterization, mRNA and protein analysis in pain relevant tissues.

Authors:  Arden G Vanderwall; Shahani Noor; Melody S Sun; Jacob E Sanchez; Xuexian O Yang; Lauren L Jantzie; Nikolaos Mellios; Erin D Milligan
Journal:  Brain Behav Immun       Date:  2017-11-04       Impact factor: 7.217

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.